Related references
Note: Only part of the references are listed.Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma
Ruoyu Shi et al.
FRONTIERS IN SURGERY (2022)
Pre-operative serum inflammation-based scores in patients with pituitary adenomas
Pedro Marques et al.
PITUITARY (2021)
Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in Glioblastoma
Johannes Wach et al.
FRONTIERS IN ONCOLOGY (2021)
Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma
Wen Lyu et al.
GLAND SURGERY (2021)
A Nomogram for Preoperatively Predicting the Ki-67 Index of a Pituitary Tumor: A Retrospective Cohort Study
Xiangming Cai et al.
FRONTIERS IN ONCOLOGY (2021)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Jacqueline Trouillas et al.
CANCERS (2020)
The impact of the MIB-1 index on facial nerve outcomes in vestibular schwannoma surgery
Johannes Wach et al.
ACTA NEUROCHIRURGICA (2020)
Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery
Michal Hlavac et al.
NEUROSURGICAL FOCUS (2020)
Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer
Yifei Zhu et al.
FRONTIERS IN ONCOLOGY (2020)
Malignancy course of pituitary adenoma in MEN1 syndrome: Clinical-Neuroradiological signs
Francesca Incandela et al.
EUROPEAN JOURNAL OF RADIOLOGY OPEN (2020)
Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning
Lorenzo Ugga et al.
NEURORADIOLOGY (2019)
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Pedro Marques et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors
Chhanda Das et al.
JOURNAL OF LABORATORY PHYSICIANS (2019)
Cardioprotective role of IGF-1 in the hypertrophied myocardium of the spontaneously hypertensive rats: A key effect on NHE-1 activity
A. M. Yeves et al.
ACTA PHYSIOLOGICA (2018)
The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study
Ming Chen et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
Min Hye Jang et al.
PLOS ONE (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Current biomarkers of invasive sporadic pituitary adenomas
Xin Zheng et al.
ANNALES D ENDOCRINOLOGIE (2016)
Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up
Juliano Coelho de Oliveira Zakir et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Long-term Results of Endonasal Endoscopic Transsphenoidal Resection of Nonfunctioning Pituitary Macroadenomas
Robert F. Dallapiazza et al.
NEUROSURGERY (2015)
Gender-dependent changes in haematological parameters in patients with Cushing's disease before and after remission
Alberto Giacinto Ambrogio et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
Juan E. Puche et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Clinical Manifestations and Diagnosis of Acromegaly
Gloria Lugo et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2012)
Brain tumor imaging in clinical trials
J. W. Henson et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): A case-control study in a series of 77 patients versus 2509 non-MEN1 patients
Jacqueline Trouillas et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Tumor Recurrence and Malignant Progression of Gangliogliomas
Michael Majores et al.
CANCER (2008)
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas
A. Fusco et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions
M Majores et al.
ACTA NEUROPATHOLOGICA (2005)
The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models
S Yakar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody
CB Pizarro et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study
GA Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index
Y Tanaka et al.
JOURNAL OF NEUROSURGERY (2003)
Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas an immunohistochemical study
E Ozer et al.
TUMORI (2003)
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease - A population-based case-control study
A Juul et al.
CIRCULATION (2002)
Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification
DMT Ho et al.
HISTOPATHOLOGY (2001)
Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas
R Kurotani et al.
MODERN PATHOLOGY (2001)
Adrenocorticotropic hormone secreting pituitary adenomas: Analysis of growth fraction using the MIB-1 antibody
L Mastronardi et al.
TUMORI (2000)
Share Paper
